Search
Sharan Murugan
Oct 6, 20242 min read
Switzerland's Swiss Medic Guidance: Transfer of Marketing Authorisation
Recently (01 October, 2024) Swissmedic released an updated guidance " Transfer of Marketing Authorisation "Â which provides detailed...
28 views0 comments
Sharan Murugan
Oct 2, 20242 min read
Australia TGA: eCTD AU Module 1 and Regional Information v3.2
The Therapeutic Goods Administration (TGA)Â of Australia has released the latest version, v3.2, (on 13 September 2024) of the eCTD AU...
30 views0 comments
Sharan Murugan
Oct 2, 20242 min read
USFDA Guidance : Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers
The U.S. Food and Drug Administration (USFDA)Â has issued comprehensive Q&A guidance titled " Electronic Systems, Electronic Records, and...
14 views0 comments
Sharan Murugan
Oct 2, 20242 min read
UK MHRA Guidance: Pre-submission Advice & Support
UK's Medicines and Healthcare products Regulatory Agency (MHRA)Â updated and released ( 1 October 2024 ) guidance " Pre-Submission Advice...
21 views0 comments
Sharan Murugan
Sep 28, 20242 min read
UK MHRA: Guidance on Applying for a Manufacturer or Wholesaler of Medicines Licence
Yesterday (27 September 2024) the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) released updated guidance on " Applying...
29 views0 comments
Sharan Murugan
Sep 25, 20242 min read
Malaysia’s NPRA: Guidance for Bioequivalence Inspection
Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) published an updated regulatory guidance on the conduct of bioequivalence...
29 views0 comments
Sharan Murugan
Sep 25, 20242 min read
India CDSCO Guidance: Pharmacovigilance Document for Marketing Authorization Holders of Pharmaceutical Products
India's CDSCO Pharmacovigilance released an updated guidance " Pharmacovigilance Guidance Document for Marketing Authorization Holders of...
29 views0 comments
Sharan Murugan
Sep 25, 20242 min read
USFDA Guidance: An Acceptable Circular of Information for the Use of Human Blood and Blood Components
The USFDA's Center for Biologics Evaluation and Research (CBER) has released the final guidance document , titled “ An Acceptable...
16 views0 comments
Sharan Murugan
Sep 22, 20242 min read
SFDA Guidance: Conducting Clinical Trials with Decentralized Elements & Integrating Randomized Controlled Trials
Guidance: Conducting Clinical Trials With Decentralized Elements The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation...
11 views0 comments
Sharan Murugan
Sep 21, 20242 min read
EMA IRIS Guide for Applicants: How to Create, Submit, and Manage IRIS Applications
On 16 September 2024 the European Medicines Agency (EMA) provided a detailed guide " IRIS guide for applicants - How to create and submit...
29 views0 comments
Sharan Murugan
Sep 15, 20242 min read
USFDA Guidance: Providing Regulatory Submissions in Electronic Format Using eCTD Specifications
This Friday (13 Septmeber, 2024) the USFDA's Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research...
47 views0 comments
Sharan Murugan
Sep 15, 20242 min read
USFDA Guidance: Amendments to Abbreviated New Drug Applications (ANDAs) Under GDUFA
FDA's Center for Drug Evaluation and Research revised the final guidance last week titled " ANDA Submissions | Amendments to Abbreviated...
47 views0 comments
Sharan Murugan
Sep 15, 20242 min read
EMA: Harnessing AI in Medicines Regulation: The Role of Large Language Models (LLMs)
The advancement of Artificial Intelligence (AI) Â is transforming many industries, and the pharmaceutical and regulatory sectors are no...
22 views0 comments
Sharan Murugan
Sep 15, 20242 min read
UK MHRA: Windsor Framework: Wholesalers & Manufacturers Guidance & Labelling and Packaging Requirements
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has released 2 updated essential guidances " Wholesalers &...
12 views0 comments
Sharan Murugan
Sep 9, 20242 min read
South Africa SAHPRA: eCTD Validation and Technical Screening for Renewals - Template
The South African Health Products Regulatory Authority (SAHPRA) has provided updated guidance for " ECTD Validation And Technical...
52 views0 comments
Sharan Murugan
Sep 6, 20242 min read
USFDA Guidance: Incorporating Voluntary Patient Preference Information Over the Total Product Life Cycle
USFDA's Center for Devices and Radiological Health (CDRH)Â and the Center for Biologics Evaluation and Research (CBER) released a draft...
32 views0 comments
Sharan Murugan
Sep 4, 20242 min read
USFDA Guidance: Control of Nitrosamine Impurities in Human Drugs
Earlier today (04 September, 2024) U.S. Food and Drug Administration's Center for Drug Evaluation and Research released the second...
84 views0 comments
Sharan Murugan
Sep 3, 20242 min read
USFDA Guidance: Bioresearch Monitoring Technical Conformance Guide
The USFDA Center for Drug Evaluation and Research issued the final guidance today (03 September 2024) " Bioresearch Monitoring...
31 views0 comments
Sharan Murugan
Aug 31, 20242 min read
Swissmedic Guidance: The Electronic Exchange of ICSRs in E2B(R3) Format through PV Gateway
The Swissmedic released an updated guidance " Electronic Exchange of ICSRs in E2B(R2) Format through PV Gateway " that provides...
34 views0 comments
Sharan Murugan
Aug 27, 20242 min read
India's: Newly Launched Indian Pharmacopoeia (IP) Online Portal and Adverse Drug Monitoring System (ADRMS) Online Portal
India has recently made significant advancements in its healthcare regulatory landscape by launching two new online portals " Adverse...
56 views0 comments